Name : FRAT1 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN2767044478
| Long name | FRAT1 Primary Polyclonal Antibody |
| Also known as | FRAT1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | FRAT1 |
| Specificity | This is a highly specific antibody against FRAT1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human FRAT1 |
| Gene ID number | 10023 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway, FRAT2 has been shown to bind xGSK-3, GBP binds to GSK-3 and inhibits this phosphorylation, Like GBP, These proteins share significant homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) binding protein, Wnt signaling is regulated in part by the activity of GSK-3, and they have since been identified as proto-oncogenes involved in tumorigenesis, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development, which phosphorylates and thereby facilitates the degradation of ?catenin, FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | FRAT1_HUMAN, Frequently rearranged in advanced T-cell lymphomas, GSK 3 binding protein FRAT1, frequently rearranged in advanced T cell lymphomas, proto oncogene FRAT1, FRAT 1 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | FRAT1 |
| Short name | FRAT1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | frequently rearranged in advanced T-cellular lymphomas (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | Cytoplasm, FRAT1 and IDBG-648818 and ENSBTAG00000007956 and 505664, FRAT1 and IDBG-84511 and ENSG00000165879 and 10023, Peg12 and IDBG-190638 and ENSMUSG00000070526 and 27412, this GO :0005737 and cytoplasm and cellular component this GO :0016055 and Wnt signaling pathway and biological process, frequently rearranged in advanced T-cell lymphomas |
| Identity | 3944 |
| Gene | FRAT1 |
| Long gene name | FRAT1, WNT signaling pathway regulator |
| Synonyms gene name | frequently rearranged in advanced T-cell lymphomas frequently rearranged in advanced T-cell lymphomas 1 |
| Locus | 10q24, 1 |
| Discovery year | 2000-04-13 |
| GenBank acession | U58975 |
| Entrez gene record | 10023 |
| Pubmed identfication | 9034327 |
| RefSeq identity | NM_005479 |
| Havana BLAST/BLAT | OTTHUMG00000018848 |